![New York City](https://d197nivf0nbma8.cloudfront.net/uploads/2024/05/AdobeStock_233647889-1-520x438.jpeg)
Naloxone Access Improved in New York City in High Overdose Areas, But Gaps Remain Across the Five Boroughs
New Maps From LDI Researchers Show Progress in Locating Programs Where the Need Is Greatest
Opioid Epidemic
In Their Own Words
Federal officials and caregivers have been in a race to combat a surge in overdoses from the combination of the opioid fentanyl and the animal sedative xylazine. The Biden Administration declared the combination an “emerging threat” in April 2023, marking the first time that designation has ever been used. It was given for the sharp rise in overdoses and skin wounds that the combination was causing across the nation.
In June a large group of experts met under the auspices of the National Institute on Drug Abuse to review testing, treatment and wound care for this combination, also called Tranq Dope. Then in July came the release of a National Response Plan.
LDI Senior Fellow Jeanmarie Perrone, a leading addiction expert at the University of Pennsylvania, was co-chair of the NIDA meeting. Here are some highlights she culled from the event.
New Maps From LDI Researchers Show Progress in Locating Programs Where the Need Is Greatest
Xylazine and Telehealth Rule Exemptions Dominate Hearing
But More Funding and Better Rules Are Needed to Help People Who Are Addicted or Homeless, LDI Experts Say
New Commentary Suggests Ways to Make Contingency Management More Effective For Drugs Like Cocaine and Methamphetamine
A Gathering of Experts Focuses in on the Positive Impact of Contingency Management
Only 1 in 3 Pregnant or Postpartum People with Private Insurance Receive Needed Treatment